BRPI0817483A2 - uso de n-fenilamidas de ácido 2-sulfonilaminobenzoico substituídas por sulfonila no tratamento da dor - Google Patents

uso de n-fenilamidas de ácido 2-sulfonilaminobenzoico substituídas por sulfonila no tratamento da dor

Info

Publication number
BRPI0817483A2
BRPI0817483A2 BRPI0817483A BRPI0817483A BRPI0817483A2 BR PI0817483 A2 BRPI0817483 A2 BR PI0817483A2 BR PI0817483 A BRPI0817483 A BR PI0817483A BR PI0817483 A BRPI0817483 A BR PI0817483A BR PI0817483 A2 BRPI0817483 A2 BR PI0817483A2
Authority
BR
Brazil
Prior art keywords
phenylamides
pain
treatment
sulfonyl substituted
sulfonylaminobenzoic acid
Prior art date
Application number
BRPI0817483A
Other languages
English (en)
Inventor
Hans Guehring
Karl Rudolphi
Martin Michaelis
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of BRPI0817483A2 publication Critical patent/BRPI0817483A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
BRPI0817483A 2007-10-05 2008-09-20 uso de n-fenilamidas de ácido 2-sulfonilaminobenzoico substituídas por sulfonila no tratamento da dor BRPI0817483A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07019521 2007-10-05
EP08013725 2008-07-31
PCT/EP2008/007953 WO2009043495A1 (en) 2007-10-05 2008-09-20 Use of sulfonyl-substituted 2-sulfonylaminobenzoic acid n-phenylamides in the treatment of pain

Publications (1)

Publication Number Publication Date
BRPI0817483A2 true BRPI0817483A2 (pt) 2016-07-26

Family

ID=40042693

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0817483A BRPI0817483A2 (pt) 2007-10-05 2008-09-20 uso de n-fenilamidas de ácido 2-sulfonilaminobenzoico substituídas por sulfonila no tratamento da dor

Country Status (16)

Country Link
US (1) US8518998B2 (pt)
EP (1) EP2207541B1 (pt)
JP (1) JP5487107B2 (pt)
KR (1) KR20100063109A (pt)
CN (1) CN101815514B (pt)
AR (1) AR071049A1 (pt)
BR (1) BRPI0817483A2 (pt)
CA (1) CA2706241C (pt)
CL (1) CL2008002942A1 (pt)
ES (1) ES2527948T3 (pt)
IL (1) IL204668A (pt)
MX (1) MX2010003071A (pt)
PA (1) PA8797801A1 (pt)
PE (1) PE20090961A1 (pt)
TW (1) TW200932247A (pt)
WO (1) WO2009043495A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5715713B2 (ja) 2011-03-10 2015-05-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 可溶性グアニル酸シクラーゼ活性化因子
JP5826393B2 (ja) 2011-08-12 2015-12-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 可溶性グアニル酸シクラーゼ活性化因子
ES2748798T3 (es) * 2012-09-07 2020-03-18 Boehringer Ingelheim Int Alcoxi pirazoles como activadores de la guanilato ciclasa soluble
ES2900815T3 (es) * 2013-03-15 2022-03-18 Scripps Research Inst Compuestos y métodos para inducir la condrogénesis
EP3172202B1 (en) 2014-07-22 2020-01-29 Boehringer Ingelheim International GmbH Heterocyclic carboxylic acids as activators of soluble guanylate cyclase
EP2990403A1 (en) 2014-08-29 2016-03-02 Novartis Tiergesundheit AG Anthranilamides, sulfonamides and nitro analogues derived therefrom as anthelmintics
CN104892466B (zh) * 2015-04-30 2018-05-29 中国科学技术大学 一种苯胺磺酰类化合物的合成及其作为hiv病毒抑制剂的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US684287A (en) * 1900-03-15 1901-10-08 Millhiser Mfg Company Bag-stringing machine.
CN1332943C (zh) * 1998-07-08 2007-08-22 萨诺费－阿文蒂斯德国有限公司 硫取代的磺酰基氨基羧酸n－芳基酰胺,其制备方法、用途以及含有该化合物的药物制剂
GB9824579D0 (en) 1998-11-10 1999-01-06 Novartis Ag Organic compounds
DE19943634A1 (de) * 1999-09-13 2001-04-12 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE10122894A1 (de) * 2001-05-11 2002-11-14 Bayer Ag Neue Sulfonat-substituierte Pyrazolopyridinderivate
DOP2003000556A (es) * 2002-01-23 2003-10-31 Warner Lambert Co Esteres hidroxamato de acido n-(4-fenil-sustituido)-antranilico.
US20040192680A1 (en) * 2002-12-20 2004-09-30 Anderson Steven N. Novel amides that activate soluble guanylate cyclase
DE102005031575A1 (de) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Verwendung von Aktivatoren der löslichen Guanylatzyklase zur Förderung der Wundheilung

Also Published As

Publication number Publication date
JP2010540581A (ja) 2010-12-24
AR071049A1 (es) 2010-05-26
CN101815514A (zh) 2010-08-25
CL2008002942A1 (es) 2009-06-05
EP2207541B1 (en) 2014-10-29
US20110021505A1 (en) 2011-01-27
US8518998B2 (en) 2013-08-27
ES2527948T3 (es) 2015-02-02
CA2706241C (en) 2015-12-22
EP2207541A1 (en) 2010-07-21
JP5487107B2 (ja) 2014-05-07
KR20100063109A (ko) 2010-06-10
IL204668A0 (en) 2010-11-30
CA2706241A1 (en) 2009-04-09
CN101815514B (zh) 2012-05-09
MX2010003071A (es) 2010-04-01
AU2008306207A1 (en) 2009-04-09
WO2009043495A1 (en) 2009-04-09
PA8797801A1 (es) 2009-06-23
HK1143756A1 (en) 2011-01-14
TW200932247A (en) 2009-08-01
IL204668A (en) 2013-10-31
PE20090961A1 (es) 2009-08-10

Similar Documents

Publication Publication Date Title
PL2037902T3 (pl) Zastosowanie kanabidiolu w użyciu w leczeniu bólu neuropatycznego
EP1854415A4 (en) SURGICAL TREATMENT DEVICE
GB0916028D0 (en) Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
BRPI0822625A2 (pt) "dispositivo espaçador modular para o tratamento de infecções por próteses"
BR112012004546A2 (pt) "terapêutica por proteínas ligantes dll4-ligantes"
IL217540A (en) Oral composition for use in oral disinfection or in treating an oral disease
IL185462A0 (en) New pharmaceutical compositions useful in the treatment of pain
EP2049713A4 (en) tissue rejection
BRPI0820477A2 (pt) Compostos de benzodiazepinona úteis no tratamento de afecções da pele
BRPI0912292A2 (pt) composições e métodos para o uso de células no tratamento do tecido cardíaco.
BRPI0816712A2 (pt) terapia de intervalo para o tratamento de tinnitus
BRPI0921604A2 (pt) formulacoes para o tratamento da dor associada ao herpes zoster agudo
IL209336B (en) Compositions for treating hyperproliferative diseases and uses thereof
EP1878421A4 (en) TOPICAL SKIN PREPARATION
BRPI1007603A2 (pt) "composição de tratamento do cabelo"
DK1863899T3 (da) Hudbehandlingspræparater
BRPI0912687A2 (pt) uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia
EP3381471C0 (en) PAIN TREATMENT
BRPI0817483A2 (pt) uso de n-fenilamidas de ácido 2-sulfonilaminobenzoico substituídas por sulfonila no tratamento da dor
BRPI0810475A2 (pt) uso de dimiracetam no tratamento de dor crônica
PT2054045E (pt) Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento da artrite e da dor
BRPI0720323A2 (pt) composto, método de tratamento, composição farmacêutica e uso do composto
BRPI0914454A2 (pt) "composição para o tratamento do tecido epitelial"
FI20095600L (fi) Koostumus ihosairauksien hoitoa varten
BRPI0818121A2 (pt) diespiro 1,2,4-trioxolano e seus métodos de fabricação e utilização

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2480 DE 17-07-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]